Overview

Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Anusol topical ointment for the relief of internal and external haemorrhoid symptoms in people with Grades I-III haemorrhoids compared to a placebo (the study medication without the active ingredients) and a benchmark product.
Phase:
Phase 3
Details
Lead Sponsor:
Church & Dwight Company, Inc.
Treatments:
Bismuth
Bismuth subgallate
Oxymetazoline
Phenylephrine
Zinc Oxide